Right On Brands (RTON) 10-Q 14 Feb 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2019	Feb. 14, 2020
Document And Entity Information
Entity Registrant Name	Right On Brands, Inc.
Entity Central Index Key	0001580262
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2019
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		777,040,806
EntityFileNumber	000-55704
EntityAddressAddressLine1	3235 Skyline Dr
EntityAddressAddressLine2	Suite 127
EntityAddressPostalZipCode	75006
EntityTaxIdentificationNumber	451994478
EntityAddressCityOrTown	Carrollton, TX
LocalPhoneNumber	736-7252
CityAreaCode	214
EntityAddressStateOrProvince	NEVADA

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Current assets
Cash	$ 15,616	$ 90,883
Accounts receivable, net of allowance	26,879	24,184
Prepaid expenses	15,575
Inventory	258,163	213,957
Total current assets	316,233	329,024
Non-current assets
Property and equipment, net of depreciation	22,712	27,451
Intangible assets, net of amortization	358	768
Right of use asset (Note 8)	102,600
Total non-current assets	125,670	28,219
Total assets	441,903	357,243
Current liabilities
Accounts payable	199,772	66,689
Accrued interest payable	48,922	30,337
Lease liability, current (Note 8)	45,600
Notes payable, net of discount	754,164	609,000
Convertible debt, net of discount	240,942	347,473
Derivative liability	484,358	1,034,939
Total current liabilities	1,773,758	2,088,438
Lease liability, non-current (Note 8)	57,000
Total liabilities	1,830,758	2,088,438
Commitments and contingencies (Note 8)
Stockholders' deficit
Common stock; par value $.001; 8,000,000,000 shares authorized 453,040,546 and 73,652,594 shares issued December 31, 2019 and March 31, 2019, respectively	453,041	73,653
Additional paid-in capital	9,964,477	8,295,767
Common stock issuable	56,050	56,050
Accumulated deficit	(11,891,860)	(10,186,102)
Total Right On Brands stockholders' deficit	(1,413,292)	(1,755,632)
Noncontrolling interest	24,437	24,437
Total stockholders' deficit	(1,388,855)	(1,731,195)
Total liabilities and stockholders' deficit	441,903	357,243
Series A Preferred Stock [Member]
Stockholders' deficit
Series A Preferred stock; 10,000,000 shares authorized of $.001 par value; 5,000,000 and 5,000,000 shares issued December 31, 2019 and March 31, 2019, respectively	$ 5,000	$ 5,000

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2019	Mar. 31, 2019
Stockholders' deficit
Common stock, shares par value	$ .001	$ .001
Common stock, shares authorized	8,000,000,000	8,000,000,000
Common stock, shares issued	453,040,546	73,652,594
Series A Preferred Stock [Member]
Stockholders' deficit
Preferred stock, shares par value	$ .001	$ .001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	5,000,000	5,000,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Revenue	$ 106,434	$ 57,476	$ 315,091	$ 153,087
Cost of goods sold	83,357	41,293	221,277	140,480
Gross profit	23,077	16,183	93,814	12,607
Operating expenses
Depreciation and amortization	1,836	679	5,149	2,822
General and administrative	101,518	46,627	336,657	141,838
Advertising and promotion	5,818	33,351	54,749	58,737
Legal and professional	37,306	25,061	169,233	51,639
Executive compensation	39,000		62,000	18,000
Consulting	36,555	374,977	68,410	1,054,813
Research and development				337
Total operating expenses	222,033	480,695	696,198	1,328,186
Other income (expense)
Interest expense	(116,783)	(784,892)	(606,687)	(981,383)
Loss on interest settlement			(8,693)
Change in fair value of derivative	145,868	(534,387)	49,230	(509,686)
Financing costs	(12,623)		(335,102)
Default penalty			(202,234)
Other income	112		112
Total other income (expense)	16,574	(1,319,279)	(1,103,374)	(1,491,069)
Net loss including noncontrolling interest	(182,382)	(1,783,791)	(1,705,758)	(2,806,648)
Net income attributable to noncontrolling interest				253
Net loss attributable to Right On Brands, Inc.	$ (182,382)	$ (1,783,791)	$ (1,705,758)	$ (2,806,395)
Loss per share
Basic loss per share	$ 0	$ (0.03)	$ (0.01)	$ (0.04)
Basic weighted average shares outstanding	387,273,071	66,366,478	230,093,250	64,930,832

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (DEFICIT) - USD ($)	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Common Stock Issuable [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Preferred Stock [Member]
Balance, shares at Mar. 31, 2018		63,543,869					5,000,000
Balance, amount at Mar. 31, 2018	$ 2,980,015	$ 63,544	$ 6,513,979	$ 474,000	$ (4,100,945)	$ 24,437	$ 5,000
Issuance of common stock for cash, Shares		3,000,000
Issuance of common stock for cash, amount	44,950	$ 3,000	3,000	38,950
Issuance of common stock for cash and warrants, shares		40,000
Issuance of common stock for cash and warrants, amount	10,000	40	9,960
Issuance of common stock for consulting services, amount	36,050			36,050
Net Income (Loss)	$ (2,806,395)				$ (2,806,395)	$ (252)
Balance, shares at Dec. 31, 2018		66,583,869					5,000,000
Balance, amount at Dec. 31, 2018	$ 264,368	$ 66,584	$ 6,526,939	$ 549,000	$ (6,907,340)	$ 24,185	$ 5,000
Balance, shares at Mar. 31, 2019		73,652,594					5,000,000
Balance, amount at Mar. 31, 2019	$ (1,731,195)	$ 73,653	$ 8,295,767	$ 56,050	$ (10,186,102)	$ 24,437	$ 5,000
Issuance of common stock for cash, Shares		24,416,666
Issuance of common stock for cash, amount	125,000	$ 24,417	80,583	20,000
Net Income (Loss)	(1,705,758)				$ (1,705,758)
Warrants issued as financing costs	33,113		33,113
Conversion of debt and interest to common stock, shares		354,971,286
Conversion of debt and interest to common stock, amount	$ 1,889,985	$ 354,971	$ 1,555,014	$ (20,000)
Balance, shares at Dec. 31, 2019		453,040,546					5,000,000
Balance, amount at Dec. 31, 2019	$ (1,388,855)	$ 453,041	$ 9,964,477	$ 56,050	$ (11,891,860)	$ 24,437	$ 5,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows provided by (used in) operating activities
Net loss	$ (1,705,758)	$ (2,806,395)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	5,149	2,822
Inventory impairment	21,137	35,387
Amortization of prepaid stock compensation		962,585
Change in fair value of derivative	(49,230)	509,686
Amortization of debt discount	533,592	192,704
Financing costs for debt issuances	335,102	782,889
Loss on interest settlement	8,693
Default penalties	$ 202,234
Common stock issuable	(20,000)
(Increase) decrease in assets
Accounts receivable	$ (2,695)	$ (92,835)
Prepaid expense	(15,575)	6,649
Inventory	(65,343)	(91,350)
Increase (decrease) in liabilities
Accounts payable	133,083	34,426
Accrued interest payable	73,094	16,037
Net cash used in operating activities	(546,517)	(447,395)
Cash flows from investing activities
Deposits		2,000
Net cash from investing activities		2,000
Cash flows from financing activities
Proceeds from convertible debt	321,250	514,500
Proceeds from notes payable	25,000
Proceeds from issuances of common stock	125,000	91,000
Net cash provided by financing activities	471,250	605,500
Decrease in cash	(75,267)	160,105
Cash-beginning of period	90,883	47,506
Cash-end of period	15,616	207,611
Right of use asset and liability, office lease (Note 8)	136,800
Recognition of right of use asset and lease liability	34,200
Convertible debt converted into common stock	810,573
Penalty accrued as note payable	121,091
Debt discount at note payable origination	25,000
Debt discount at convertible note origination	327,945
Derivative at convertible note origination	608,211
Accrued interest converted to common stock	$ 54,509

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	The interim unaudited condensed financial statements and footnotes have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) on the same basis as the annual financial statements; and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. They do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these condensed financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended March 31, 2019 filed with the SEC on form 10-K/A on July 29, 2019. Certain amounts in the prior period financial statements regarding inventory impairment have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss. Formation and Business Activity Right on Brands, Inc. (“we” or “our” or “the Company” or “Right On Brands”) was incorporated under the laws of the State of Nevada on April 1, 2011, as HealthTalk Live, Inc. On August 10, 2017, the Company amended is articles of incorporation and changed its name to Right On Brands, Inc. On August 31, 2017 the Company common shares commenced trading under the new stock symbol OTC Pink: RTON. Right On Brands is a health and wellness focused company developing and marketing our brands. Cash and Cash Equivalents The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. Property and Equipment Property and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, from one to five years. The cost of building the Company’s website has been capitalized and amortized over a period of three years. Expenditures for minor enhancements and maintenance are expensed as incurred. Inventory Inventories are stated at the lower of cost (average cost) or market (net realizable value). As of December 31, 2019, and March 31, 2019, inventory consisted of the following: As of December 31, 2019 As of March 31, 2019 Raw materials $ 6,843 $ 43,796 Work-in-process 30,611 30,611 Finished Goods 220,709 139,550 Ending Balance $ 258,163 $ 213,957 During the nine months ended December 31, 2019 and 2018, inventory impairments or $21,137 and $35,387 were recognized due to expired products. These are included in Cost of Goods Sold in the accompanying consolidated statement of operations. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of hemp products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. The transfer of control of products to our customers is typically based on written sales terms that do not allow for a right of return after 30 days from the date of purchase. Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery, and may allow discounts for early payment. We estimate and reserve for our bad debt exposure based on our experience with past due accounts and collectability, the aging of accounts receivable and our analysis of customer data. Income Taxes The Company is subject to income taxes in the U.S. Significant judgment is required in evaluating our uncertain tax positions and determining our provision for income taxes. In accordance with the Financial Accounting Standards Board (FASB) ASC Topic 740, “Income Taxes,” the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. The Company accounts for income tax under the provisions of FASB ASC Topic 740, “Income Taxes”, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns. Deferred income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities. Valuation allowances are established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized. Fair Value of Financial Instruments In accordance with the reporting requirements of ASC Topic 825, Financial Instruments Consequently, the Company did not have any fair value adjustments for assets and liabilities measured at fair value at the balance sheet dates, nor gains or losses reported in the statements of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held during the three months ended December 31, 2019 and 2018, except as disclosed. Fair Value Measurement The Company did not have any Level 1 or Level 2 assets and liabilities at December 31, 2019 and 2018. The derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities during the nine months ended December 31, 2019: Balance at March 31, 2019 $ 1,034,939 Additions to derivative liability for new debt 608,211 Additions to derivative liability for penalty 81,143 Reclass to equity upon conversion/cancellation (1,190,705 ) Change in fair value (49,230 ) Balance at December 31, 2019 $ 484,358 From time to time, the Company enters into convertible promissory note agreements (Note 5). These notes are convertible at a fraction of the stock closing price near the conversion date. Additionally, the conversion price, as well as other terms including interest rates, adjust if any future financings have more favorable terms. The conversion features of these notes meet the definition of a derivative which therefore requires bifurcation and are accounted for as a derivative liability. The Company estimated the fair value of the conversion feature derivatives embedded in the convertible promissory notes based on assumptions used in the Black Scholes pricing model. At December 31, 2019 and March 31, 2019, the fair value of the derivative liabilities of convertible notes was estimated using the following weighted-average inputs: the price of the Company’s common stock of $0.001 and $0.045, respectively; a risk-free interest rate ranging from 1.66% to 2.62%, and expected volatility of the Company’s common stock ranging from 158% to 635%, various estimated exercise prices, and terms under one year. Convertible Instruments The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC Topic 815, Derivatives and Hedging Activities Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. Earnings (Loss) Per Share Basic earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company had no potential additional dilutive securities outstanding at December 31, 2019, except as follows. These were excluded from the earnings per share computation since their effect would be anti-dilutive. Potential additional common stock shares Potentially dilutive security: Preferred stock 25,000,000 Warrants 19,230,000 Options 8,000,000 Convertible debt 613,058,462 Potentially dilutive securities 665,288,462 During the nine months ended December 31, 2019 stock warrants for 11,250,000 shares were issued in connection with financing received. An additional warrant to purchase 500,000 shares was issued with a subscription agreement September 16, 2019. In connection with the appointment of Advisory Board members, warrants for 3,000,000 shares were issued during October 2019. A summary of the status of the Company’s option and warrant grants as of December 31, 2019 and the changes during the fiscal quarter then ended is presented below: Weighted-Average Shares Exercise Price Outstanding, March 31, 2019 12,480,000 $ 0.17 Granted 14,750,000 .04 Exercised - - Expired - - Outstanding, December 31, 2019 27,230,000 $ 0.11 Options and warrants exercisable at December 31, 2019 27,230,000 $ 0.11 Recent Accounting Pronouncements During the quarter ended December 31, 2019, there were several new accounting pronouncements issued by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s financial statements. In February 2016, the FASB issued ASU 2016-02, Leases

GOING CONCERN

GOING CONCERN	9 Months Ended
	Dec. 31, 2019
GOING CONCERN
NOTE 2. GOING CONCERN	The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern, which is dependent upon the Company’s ability to obtain sufficient financing or establish itself as a profitable business. As of December 31, 2019 and 2018, the Company had an accumulated deficit of $11,891,860 and $6,907,339, respectively. For the nine months ended December 31, 2019 and 2018, the Company incurred net losses of $1,705,758 and $2,806,395, respectively. The Company has had minimal revenue earned since inception and a lack of operational history. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern. While the Company is attempting to generate greater revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of additional public and/or private offerings of its stock and/or debt and/or convertible debt. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should the Company be unable to continue in operation.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	9 Months Ended
	Dec. 31, 2019
PROPERTY AND EQUIPMENT
NOTE 3. PROPERTY AND EQUIPMENT	As of December 31, 2019 As of March 31, 2019 Website development $ 88,965 $ 88,965 Automobile 31,596 31,596 Studio and office equipment 5,957 5,957 Tenant improvements 11,135 11,135 137,653 137,653 Less: accumulated depreciation (114,941 ) (110,202 ) Ending Balance $ 22,712 $ 27,451 Depreciation expense for the nine months ended December 31, 2019 and 2018 was $4,739 and $2,822, respectively. The Company also has capitalized intangible assets consisting of trademarks valued at a cost of $1,024 as of December 31, 2019 and March 31, 2019. Amortization expense for the nine months ended December 31, 2019 and 2018 was $410 and $256, respectively.

NONCONTROLLING INTEREST

NONCONTROLLING INTEREST	9 Months Ended
	Dec. 31, 2019
NONCONTROLLING INTEREST
NOTE 4. NONCONTROLLING INTEREST	Investments in partnerships, joint ventures and less-than-majority-owned subsidiaries in which we have significant influence are accounted for under the equity method. As of March 31, 2018, the Company’s consolidated financial statements includes a venture for the development of a commercial bottled water operation near Browning, Montana. The new venture is operated through Spring Hill Water Company, LLC, a Nevada limited liability company (“Spring Hill”). Spring Hill is 49% owned by our newly-formed subsidiary corporation, Humble Water Company, and 51% owned by Doore, LLC. Doore, LLC, which serves as the manager of Spring Hill, has contributed the land and water source to be used in the new operation through a Land & Water Lease Agreement under which Spring Hill will have the use of 2 acres of land and no less than 5 acre-feet of water for an initial term of 25 years and at a lease rate of $1 per year. Through Humble Water Company, our initial capital contribution to Spring Hill was approximately $100,000 to be used in commencing operations. In addition, we have committed to provide additional capital to be used for a bottling facility and equipment, in an amount up to $530,000, by January 1, 2020. Should we fail to provide this additional capital, our ownership percentage in Spring Hill will be reduced from 49% to 20%. Although we hold a minority ownership percentage in Spring Hill, we will have voting control over the company with 75% of the voting membership units. Further, 100% of the losses, expenditures, and deductions from Spring Hill will be allocated to our subsidiary, Humble Water Company. The activity of Spring Hill is accounted for under the voting interest method and we consolidate 100% of the business activity and record 25% of noncontrolling interest on the balance sheet and 0% of the net losses based on the terms of the agreement. As of December 31, 2019, the noncontrolling interest was $24,437 in the accompanying consolidated financial statements. As of December 31, 2019, our total investment into Spring Hill to date was $101,470. Since entering into the venture, there have been no significant operations or expenditures in the joint venture except for expensing the remainder of the prepaid lease due to the low likelihood of utilization.

CONVERTIBLE DEBT

CONVERTIBLE DEBT	9 Months Ended
	Dec. 31, 2019
CONVERTIBLE DEBT
NOTE 5. CONVERTIBLE DEBT	During October 2016, the Company extinguished $129,549 of debt in exchange for 5,000,000 shares of newly issued common stock. The original note had a maturity date of November 11, 2016 and no interest rate. A total of 4,200,000 shares were issued to three of the four noteholders. As of December 31, 2016, the remaining balance of 800,000 shares of common stock was pending issuance to one noteholder, so common stock payable of $474,000 was recorded in the accompanying consolidated statement of stockholders’ equity. As of early 2019 the shares were still pending issuance; accordingly, the Company reclassified the amount due to the noteholder to notes payable at the fair value of the common stock. See Note 9, Subsequent Events On July 7, 2016, the Company issued a convertible promissory note with an entity for $25,000. The unsecured note bears interest at 6% per annum and is due on January 7, 2017. This note is convertible at $0.10 per share and can be converted on or before the maturity date. The Company and lender mutually agreed to extend the maturity date of the note to March 30, 2020. On November 21, 2017, the Company issued a convertible promissory note with an entity for $20,000. The unsecured note bears interest at 6% per annum and was due on May 21, 2018 but was extended to March 30, 2020. This note is convertible at $0.20 per share and can be converted on or before the maturity date. See note 7. On February 12, 2019, Noteholder 1 submitted a notice of conversion for $125,000 principal and $11,250 accrued interest after the note was in default. The note terms provided a $3,000 daily fee for failure to deliver common stock prior to a deadline of two days after the conversion notice. The shares due under the conversion were not issued until May 8, 2019. Accordingly, an additional note payable of $135,000 was recorded as a penalty at March 31, 2019. An additional $114,000 was accrued as a penalty during the quarter ended June 30, 2019 and remains outstanding. On November 22, 2019, the Company issued a $50,000 promissory note to an individual for a $25,000 cash borrowing. Accordingly, a $25,000 discount was recorded at issuance, $6,164 of which was amortized by December 31, 2019. The non-interest bearing note is due February 20, 2020. At December 31, 2019, the Company’s short-term convertible promissory notes carrying a 12% interest rate and related debt discount and derivative liability are summarized as follows: Gross amount Net amounts Corresponding Gross amount offset by of liabilities Derivative Note holder of liability debt discount presented Balance Noteholder 2 $ 21,487 $ - $ 21,487 $ 14,350 Noteholder 3 37,125 - 37,125 21,470 Noteholder 5 318,150 204,026 114,124 437,118 Noteholder 6 21,206 - 21,206 11,420 Other notes 47,000 - 47,000 - $ 444,968 $ 204,026 $ 240,942 $ 484,358 During the nine months ended December 31, 2019, six convertible note holders submitted notices of conversion for a portion of the principal and interest owing to them totaling $865,082. The conversions resulted in the settlement of $1,190,705 of the derivative liability, an $8,693 loss on settlement of interest payable, and the issuance of 354,971,286 shares of common stock. The convertible debt held by noteholders 3 and 6 is in default at December 31, 2019. At the noteholder’s discretion, if notice is given to the Company, additional penalties would be due. During January 2020, the penalties assessed totaled $12,500 and penalties of $5,551 and the remainder of the principal and interest due under the note was settled through the issuance of common stock. See Note 9. These fiscal 2019 note agreements require a certain number of shares be reserved so that they are readily available for note conversion. As of December 31, 2019 and March 31, 2019, we had approximately 5.3 billion shares and 398 million shares, respectively, of our common stock reserved or designated for future issuance upon conversion of outstanding convertible promissory notes. As of December 31, 2019, one note had fewer shares reserved than required under the terms of the note agreements. During the nine months ended December 31, 2019 and 2018, respectively, interest expense was $73,094 and $11,435. During the nine months ended December 31, 2019 and 2018, respectively, amortization of debt discount was $533,592 and $192,704.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Dec. 31, 2019
STOCKHOLDERS' EQUITY
NOTE 6. STOCKHOLDERS' EQUITY	Series A Preferred Stock The Series A Preferred Stock is convertible to common stock at a rate of five shares for every share held and the holder(s) have the right to cast a total of fifty-percent (50%) plus one votes on all matters submitted to a vote of holder of the Company’s common stock. Our Series A Preferred Stock ranks equally, on an as-converted basis, to our common stock with respect to rights upon winding up, dissolution, or liquidation. Our Series A Preferred Stock does not have any special dividend rights. On October 1, 2016, the Company issued 5,000,000 shares of our Series A Preferred Stock to Daniel Crawford in exchange for 10,000,000 shares of Series A Preferred Stock in Humbly Hemp. Common Stock During the nine months ended December 31, 2019, the Company issued a total of 354,971,286 shares of common stock to six noteholders in connection with the settlement of principal and interest totaling $865,082. During the nine months ending December 31, 2019, the Company issued several subscription agreements for the purchase of common stock by various investors at a price ranging from $.0025 to $.03. A total of 24,416,666 shares of common stock were issued during the nine months ended December 31, 2019 for cash proceeds received totaling $125,000.

RELATED PARTY

RELATED PARTY	9 Months Ended
	Dec. 31, 2019
RELATED PARTY
NOTE 7. RELATED PARTY	During December 2017, the Company entered into a consulting agreement with Dr. Ashok Patel, our current President, to serve as Director of Product Development. Consideration for services under the agreement provided for the issuance of 700,000 shares of common stock of the Company at the time of execution of the agreement, and the following two anniversaries of the agreement. At December 31, 2018, the first anniversary shares had yet to be issued. Accordingly, they are reported in the accompanying consolidated statement of stockholders’ equity (deficit) as common stock issuable. The trustee of La Dulce Vita Trust (LDVT) is the aunt of Daniel Crawford, the Company’s majority voting holder and the sister of Jerry Grisaffi, the Company’s CEO and Board of Directors Chairman. At December 31, 2019 and March 31, 2019, $474,000 is owed to LDVT reported in notes payable, and $22,000 is included in convertible debt on the accompanying consolidated balance sheets. See Note 9, Subsequent Events On April 16, 2018, the Company entered into an operating agreement with Centre Manufacturing, Inc. (“Centre”) and formed an LLC owned 51% by the Company and 49% owned by Centre, but all income and losses will be split evenly. The owner of Centre is the President of the Company. On June 19, 2018, the Company formed a majority owned subsidiary, Endo & Centre Venture LLC. No significant activity has occurred during the nine months ended December 31, 2019 and 2018, respectively. During the nine months ended December 31, 2019 and 2018, the Company purchased inventory totaling $12,400 and $76,946 from Centre, respectively. The Company owed Centre $0 and $26,791, respectively, at December 31, 2019 and March 31, 2019 which is included in accounts payable on the accompanying consolidated balance sheets. On October 1, 2019 the Company appointed three members to an advisory board and issued each member a warrant convertible into 1,000,000 shares of common stock at $.01 per share.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Dec. 31, 2019
COMMITMENTS AND CONTINGENCIES
NOTE 8. COMMITMENTS AND CONTINGENCIES	On April 1, 2019 the Company entered into a three-year office and warehouse lease of approximately 5,700 square feet in Carrollton, Texas. At the inception of the lease, the Company adopted ASC 842 requiring the recording of assets and liabilities related to leases on the balance sheet. The Company records rent on straight-line basis over the terms of the underlying lease. Rent expense for the nine months ended December 31, 2019 and 2018 was $34,200 and $0, respectively. Aggregate future lease liability expense under ASC 842 are as follows: Years Ending March 31, Amount 2020 $ 11,400 2021 45,600 2022 45,600 $ 102,600 There is a dispute between the Company and the holder of a convertible note regarding the timing of the conversion. As of December 31, 2019, the full amount of the penalty totaling $114,000 has been recorded on the accompanying consolidated balance sheet, and neither side has filed formal legal proceedings against the other side and negotiations are ongoing to resolve the matter.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Dec. 31, 2019
SUBSEQUENT EVENTS
NOTE 9. SUBSEQUENT EVENTS	During January 2020, the $22,000 notes payable with LDVT (Note 7) were sold to another party and amended to a total principal amount of $22,580 with a conversion price similar to that of other convertible note holders. During February 2020, the Company issued 800,000 common stock shares to LDVT pursuant to the October 2016 debt extinguishment (see Notes 5 and 7). As a result, the note payable of $474,000 is no longer outstanding. On February 12, 2020, the Company entered into a Letter of Intent with Choice Wellness Brands, Inc., Wyoming corporation (“Choice”). Under the terms of the Letter of Intent, the Company will acquire 100% of the ownership of Choice in exchange for the issuance of a new class of preferred stock that will have the effect of giving the shareholders of Choice a 30% equity interest in the Company. This transaction will not result in a change in control of the Company. The Company anticipates that the acquisition of Choice will be completed by February 28, 2020. On February 13, 2020, the Company issued a $100,000 convertible promissory note to Noteholder 6. The note bears interest at 12%, matures December 13, 2020, and is convertible into shares of the Company’s common stock at a 40% discount. Upon note issuance, 40,700,000 shares were authorized for issuance as a commitment fee. Subsequent to December 31, 2019 the Company issued common stock for settlement of convertible debt as summarized below: Shares Penalty Principal Noteholder Issued Settled Converted Noteholder 6 90,500,260 $ - $ 21,206 Noteholder 3 232,700,000 $ 5,551 25,000 323,200,260 $ 5,551 $ 46,206

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Formation and Business Activity	Right on Brands, Inc. (“we” or “our” or “the Company” or “Right On Brands”) was incorporated under the laws of the State of Nevada on April 1, 2011, as HealthTalk Live, Inc. On August 10, 2017, the Company amended is articles of incorporation and changed its name to Right On Brands, Inc. On August 31, 2017 the Company common shares commenced trading under the new stock symbol OTC Pink: RTON. Right On Brands is a health and wellness focused company developing and marketing our brands.
Cash and Cash Equivalents	The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.
Property and Equipment	Property and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, from one to five years. The cost of building the Company’s website has been capitalized and amortized over a period of three years. Expenditures for minor enhancements and maintenance are expensed as incurred.
Inventory	Inventories are stated at the lower of cost (average cost) or market (net realizable value). As of December 31, 2019, and March 31, 2019, inventory consisted of the following: As of December 31, 2019 As of March 31, 2019 Raw materials $ 6,843 $ 43,796 Work-in-process 30,611 30,611 Finished Goods 220,709 139,550 Ending Balance $ 258,163 $ 213,957 During the nine months ended December 31, 2019 and 2018, inventory impairments or $21,137 and $35,387 were recognized due to expired products. These are included in Cost of Goods Sold in the accompanying consolidated statement of operations.
Use of Estimates	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition	We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of hemp products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. The transfer of control of products to our customers is typically based on written sales terms that do not allow for a right of return after 30 days from the date of purchase. Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery, and may allow discounts for early payment. We estimate and reserve for our bad debt exposure based on our experience with past due accounts and collectability, the aging of accounts receivable and our analysis of customer data.
Income Taxes	The Company is subject to income taxes in the U.S. Significant judgment is required in evaluating our uncertain tax positions and determining our provision for income taxes. In accordance with the Financial Accounting Standards Board (FASB) ASC Topic 740, “Income Taxes,” the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. The Company accounts for income tax under the provisions of FASB ASC Topic 740, “Income Taxes”, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns. Deferred income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities. Valuation allowances are established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.
Fair Value of Financial Instruments	In accordance with the reporting requirements of ASC Topic 825, Financial Instruments Consequently, the Company did not have any fair value adjustments for assets and liabilities measured at fair value at the balance sheet dates, nor gains or losses reported in the statements of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held during the three months ended December 31, 2019 and 2018, except as disclosed.
Fair Value Measurement	The Company did not have any Level 1 or Level 2 assets and liabilities at December 31, 2019 and 2018. The derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities during the nine months ended December 31, 2019: Balance at March 31, 2019 $ 1,034,939 Additions to derivative liability for new debt 608,211 Additions to derivative liability for penalty 81,143 Reclass to equity upon conversion/cancellation (1,190,705 ) Change in fair value (49,230 ) Balance at December 31, 2019 $ 484,358 From time to time, the Company enters into convertible promissory note agreements (Note 5). These notes are convertible at a fraction of the stock closing price near the conversion date. Additionally, the conversion price, as well as other terms including interest rates, adjust if any future financings have more favorable terms. The conversion features of these notes meet the definition of a derivative which therefore requires bifurcation and are accounted for as a derivative liability. The Company estimated the fair value of the conversion feature derivatives embedded in the convertible promissory notes based on assumptions used in the Black Scholes pricing model. At December 31, 2019 and March 31, 2019, the fair value of the derivative liabilities of convertible notes was estimated using the following weighted-average inputs: the price of the Company’s common stock of $0.001 and $0.045, respectively; a risk-free interest rate ranging from 1.66% to 2.62%, and expected volatility of the Company’s common stock ranging from 158% to 635%, various estimated exercise prices, and terms under one year.
Convertible Instruments	The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC Topic 815, Derivatives and Hedging Activities Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
Earnings (Loss) Per Share	Basic earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company had no potential additional dilutive securities outstanding at December 31, 2019, except as follows. These were excluded from the earnings per share computation since their effect would be anti-dilutive. Potential additional common stock shares Potentially dilutive security: Preferred stock 25,000,000 Warrants 19,230,000 Options 8,000,000 Convertible debt 613,058,462 Potentially dilutive securities 665,288,462 During the nine months ended December 31, 2019 stock warrants for 11,250,000 shares were issued in connection with financing received. An additional warrant to purchase 500,000 shares was issued with a subscription agreement September 16, 2019. In connection with the appointment of Advisory Board members, warrants for 3,000,000 shares were issued during October 2019. A summary of the status of the Company’s option and warrant grants as of December 31, 2019 and the changes during the fiscal quarter then ended is presented below: Weighted-Average Shares Exercise Price Outstanding, March 31, 2019 12,480,000 $ 0.17 Granted 14,750,000 .04 Exercised - - Expired - - Outstanding, December 31, 2019 27,230,000 $ 0.11 Options and warrants exercisable at December 31, 2019 27,230,000 $ 0.11
Recent Accounting Pronouncements	During the quarter ended December 31, 2019, there were several new accounting pronouncements issued by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s financial statements. In February 2016, the FASB issued ASU 2016-02, Leases

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Schedule of Inventory	As of December 31, 2019 As of March 31, 2019 Raw materials $ 6,843 $ 43,796 Work-in-process 30,611 30,611 Finished Goods 220,709 139,550 Ending Balance $ 258,163 $ 213,957
Summary of activity of derivative liabilities	Balance at March 31, 2019 $ 1,034,939 Additions to derivative liability for new debt 608,211 Additions to derivative liability for penalty 81,143 Reclass to equity upon conversion/cancellation (1,190,705 ) Change in fair value (49,230 ) Balance at December 31, 2019 $ 484,358
Summary of potential additional dilutive securities outstanding	Potential additional common stock shares Potentially dilutive security: Preferred stock 25,000,000 Warrants 19,230,000 Options 8,000,000 Convertible debt 613,058,462 Potentially dilutive securities 665,288,462
Summary of option and warrant grants	Weighted-Average Shares Exercise Price Outstanding, March 31, 2019 12,480,000 $ 0.17 Granted 14,750,000 .04 Exercised - - Expired - - Outstanding, December 31, 2019 27,230,000 $ 0.11 Options and warrants exercisable at December 31, 2019 27,230,000 $ 0.11

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Dec. 31, 2019
PROPERTY AND EQUIPMENT
Summary of Property And Equipment	As of December 31, 2019 As of March 31, 2019 Website development $ 88,965 $ 88,965 Automobile 31,596 31,596 Studio and office equipment 5,957 5,957 Tenant improvements 11,135 11,135 137,653 137,653 Less: accumulated depreciation (114,941 ) (110,202 ) Ending Balance $ 22,712 $ 27,451

CONVERTIBLE DEBT (Tables)

CONVERTIBLE DEBT (Tables)	9 Months Ended
	Dec. 31, 2019
CONVERTIBLE DEBT (Tables)
Summary of convertible debt	Note holder Gross amount of liability Gross amount offset by debt discount Net amounts of liabilities presented Corresponding Derivative Balance Noteholder 2 $ 21,487 $ - $ 21,487 $ 14,350 Noteholder 3 37,125 - 37,125 21,470 Noteholder 5 318,150 204,026 114,124 437,118 Noteholder 6 21,206 - 21,206 11,420 Other notes 47,000 - 47,000 - $ 444,968 $ 204,026 $ 240,942 $ 484,358

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Summary of aggregate future lease liability expense	Years Ending March 31, Amount 2020 $ 11,400 2021 45,600 2022 45,600 $ 102,600

SUBSEQUENT EVENTS (Tables)

SUBSEQUENT EVENTS (Tables)	9 Months Ended
	Dec. 31, 2019
CONVERTIBLE DEBT (Tables)
Summary of common stock for settlement of convertible debt	Shares Penalty Principal Noteholder Issued Settled Converted Noteholder 6 90,500,260 $ - $ 21,206 Noteholder 3 232,700,000 $ 5,551 25,000 323,200,260 $ 5,551 $ 46,206

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Raw materials	$ 6,843	$ 43,796
Work-in-process	30,611	30,611
Finished Goods	220,709	139,550
Ending Balance	$ 258,163	$ 213,957

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	9 Months Ended
	Dec. 31, 2019USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Balance at March 31, 2019	$ 1,034,939
Additions to derivative liability for new debt	608,211
Additions to derivative liability for penalty	81,143
Reclass to equity upon conversion/cancellation	(1,190,705)
Change in fair value	(49,230)
Balance at December 31, 2019	$ 484,358

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)	9 Months Ended
	Dec. 31, 2019shares
Potentially dilutive securities:
Potentially dilutive securities	665,288,462
Convertible Debt [Member]
Potentially dilutive securities:
Potentially dilutive securities	613,058,462
Warrants [Member]
Potentially dilutive securities:
Potentially dilutive securities	19,230,000
Options [Member]
Potentially dilutive securities:
Potentially dilutive securities	8,000,000
Preferred Stock [Member]
Potentially dilutive securities:
Potentially dilutive securities	25,000,000

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)	9 Months Ended
	Dec. 31, 2019$ / sharesshares
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Number of Shares Outstanding, March 31, 2019 | shares	12,480,000
Number of shares, Granted | shares	14,750,000
Number of shares, Exercised | shares
Number of shares, Expired | shares
Number of Shares Outstanding, December 31, 2019 | shares	27,230,000
Number of shares, Options and warrants exercisable at December 31, 2019 | shares	27,230,000
Weighted Average Exercise Price Outstanding, March 31, 2019 | $ / shares	$ 0.17
Weighted average Exercise Price, Granted | $ / shares	0.04
Weighted average Exercise Price, Exercised | $ / shares
Weighted average Exercise Price, Expired | $ / shares
Weighted Average Exercise Price Outstanding, March 31, 2019 | $ / shares	0.11
Weighted average Exercise Price, Options and warrants exercisable at December 31, 2019 | $ / shares	$ 0.11

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Oct. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Sep. 16, 2019
Date of incorporation		Apr. 1, 2011
Inventory impairment		$ 21,137	$ 35,387
State of incorporation		Nevada
Period of sale return		30 days
Building [Member]
Period of amortization		3 years
Maximum [Member] | Property and Equipment [Member]
Estimated useful lives		5 years
Minimum [Member] | Property and Equipment [Member]
Estimated useful lives		1 year
Derivative liability of convertible notes [Member] | Maximum [Member]
Common stock price per share		$ 0.045
Risk free interest rate		2.62%
Expected volatility rate		635.00%
Derivative liability of convertible notes [Member] | Minimum [Member]
Common stock price per share		$ 0.001
Risk free interest rate		1.66%
Expected volatility rate		158.00%
Warrants [Member]
Common stock shares reserved for future issuance		11,250,000
Additional warrant [Member]
Common stock shares reserved for future issuance				500,000
Advisory Board Members [Member] | October 1, 2019 [Member]
Stock warrants issued	1,000,000	3,000,000

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
GOING CONCERN (Details Narrative)
Accumulated deficit	$ (11,891,860)	$ (6,907,339)	$ (11,891,860)	$ (6,907,339)	$ (10,186,102)
Net loss	$ (182,382)	$ (1,783,791)	$ (1,705,758)	$ (2,806,395)

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Property and equipment, gross	$ 137,653	$ 137,653
Less: accumulated depreciation and amortization	(114,941)	(110,202)
Ending balance	22,712	27,451
Website development [Member]
Property and equipment, gross	88,965	88,965
Automobile [Member]
Property and equipment, gross	31,596	31,596
Studio and office equipment [Member]
Property and equipment, gross	5,957	5,957
Tenant Improvements [Member]
Property and equipment, gross	$ 11,135	$ 11,135

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	$ 4,739	$ 2,822
Amortization expense	410	$ 256
Capitalized intangible assets	$ 1,024		$ 1,024

NONCONTROLLING INTEREST (Detail

NONCONTROLLING INTEREST (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2019	Mar. 31, 2019
Investments		$ 101,470
Noncontrolling interest		$ 24,437	$ 24,437
Spring Hill Water Company [Member]
Voting membership units, percentage		75.00%
Lease agreement description	Spring Hill will have the use of 2 acres of land and no less than 5 acre-feet of water for an initial term of 25 years and at a lease rate of $1 per year.
Capital contribution	$ 100,000
Lease term	25 years
Lease rate per year	$ 1
Losses,expenditures, and deductions Percentage		100.00%
Terms of the agreement description	The activity of Spring Hill is accounted for under the voting interest method and we consolidate 100% of the business activity and record 25% of noncontrolling interest on the balance sheet and 0% of the net losses based on the terms of the agreement.
Humble Water Company [Member]
Ownership percentage		49.00%
Doore, LLC [Member]
Ownership percentage			51.00%
Bottling Facility And Equipment [Member]
Commitment to additional capital		$ 530,000
Commitment to additional capital term	3 years
Failure commitment to additional capital contrbution	Should we fail to provide this additional capital, our ownership percentage in Spring Hill will be reduced from 49% to 20%.

CONVERTIBLE DEBT (Details )

CONVERTIBLE DEBT (Details ) - USD ($)	9 Months Ended
	Dec. 31, 2019	Mar. 31, 2019
Derivative liability	$ 484,358	$ 1,034,939
Noteholder 2 [Member]
Derivative liability	14,350
Gross amount of liability	21,487
Gross amount offset by debt discount
Net amounts of liabilities presented	21,487
Noteholder 3 [Member]
Derivative liability	21,470
Gross amount of liability	37,125
Gross amount offset by debt discount
Net amounts of liabilities presented	37,125
Noteholder 6 [Member]
Derivative liability	11,420
Gross amount of liability	21,206
Gross amount offset by debt discount
Net amounts of liabilities presented	21,206
Noteholder 5 [Member]
Derivative liability	437,118
Gross amount of liability	318,150
Gross amount offset by debt discount	204,026
Net amounts of liabilities presented	114,124
Other Notes [Member]
Derivative liability
Gross amount of liability	47,000
Gross amount offset by debt discount
Net amounts of liabilities presented	47,000
Total [Member]
Derivative liability	484,358
Gross amount of liability	444,968
Gross amount offset by debt discount	204,026
Net amounts of liabilities presented	$ 240,942

CONVERTIBLE DEBT (Details Narra

CONVERTIBLE DEBT (Details Narrative) - USD ($)	Oct. 14, 2019	Feb. 12, 2019	Jan. 31, 2020	Dec. 31, 2019	Nov. 22, 2019	Oct. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2016
Interest expenses									$ 73,094	$ 11,435
Accrued interest payable				$ 51,023			$ 51,023		51,023		$ 30,337
Reclass to equity upon conversion/cancellation									(1,190,705)
Loss on interest settlement									(8,693)
Debt instrument converted amount									$ 1,740,884
Conversion of debt and interest to common stock									354,971,286
Amortization of debt discount									$ 533,592	192,704
Common stock, shares issued				141,956,991			141,956,991		141,956,991		73,652,594
Debt instrument converted amount									$ 865,082
Common stock, shares issued				453,040,546			453,040,546		453,040,546		73,652,594
Proceeds from issuance of debt									$ 321,250	$ 514,500
Additional penalty				$ 114,000			$ 114,000		$ 114,000
November 21, 2017 [Member]
Debt due date									May 21, 2018
Convertible note payable				$ 20,000			$ 20,000		$ 20,000
Interest rate				6.00%			6.00%		6.00%
Debt conversion price				$ 0.20			$ 0.20		$ 0.20
Extended maturity date									Mar. 30, 2020
July 7, 2016 [Member]
Debt due date									Jan. 7, 2017
Convertible note payable				$ 25,000			$ 25,000		$ 25,000
Interest rate				6.00%			6.00%		6.00%
Debt conversion price				$ 0.10			$ 0.10		$ 0.10
Extended maturity date									Mar. 30, 2020
April 11, 2016 [Member]
Debt due date											Feb. 7, 2017
Convertible note payable				$ 10,000			$ 10,000		$ 10,000
Interest rate				8.00%			8.00%		8.00%
Debt conversion price				$ 0.01			$ 0.01		$ 0.01
Extended maturity date											Mar. 10, 2017
Convertible note principal amount, amount											$ 1,000	$ 7,000
Convertible note principal amount converted into common stock, shares											100,000	700,000
Convertible Debt [Member]
Common stock, shares issued						5,000,000
Extinguishment of debt						$ 129,549
Promissory note [Member] | Individual [Member]
Amortization of debt discount					$ 6,164
Promissory note issued					50,000
Proceeds from issuance of debt					25,000
Discount on issuance of promissory note					$ 25,000
Debt due date					Feb. 20, 2020
Interest rate				12.00%
Convertible promissory note [Member]
Shares issuable upon conversion of convertible debt				5,300,000,000			5,300,000,000		5,300,000,000		398,000,000
Noteholder One [Member]
Shares issuable upon conversion of convertible debt													800,000
Notice of debt conversion, principal		$ 125,000
Notice of debt conversion, accrued interest		11,250
Periodic penalty upon failure to deliver common stock upon notice		$ 3,000
Frequency of periodic payments		Daily
Note payable recognized as a penalty											$ 135,000
Additional penalty				$ 114,000			$ 114,000		$ 114,000
Common stock payable, fair value													$ 474,000
Noteholder Three [Member]
Common stock, shares issued						4,200,000
Noteholder Five [Member] | Convertible promissory note [Member]
Debt due date	Oct. 14, 2020
Subsequent Event [Member]
Debt instrument converted amount									46,206
Penalties, Debt settlement			12,500
Penalty Settled									5,551
Subsequent Event [Member] | Noteholder Three [Member]
Debt instrument converted amount									25,000
Penalty Settled			$ 5,551						$ 5,551

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Oct. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019	Oct. 01, 2016
Issuance of common stock for cash, Shares		24,416,666
Issuance of common stock for cash, Amount		$ 125,000	$ 10,000
Debt instrument converted amount		$ 865,082
Conversion of debt and interest to common stock		354,971,286
Series A Preferred Stock [Member]
Convertible preferred stock, terms of conversion feature		The Series A Preferred Stock is convertible to common stock at a rate of five shares for every share held and the holder(s) have the right to cast a total of fifty-percent (50%) plus one votes on all matters submitted to a vote of holder of the Company’s common stock.
Preferred Shares issued		5,000,000		5,000,000
Subsequent Event [Member]
Debt instrument converted amount		$ 46,206
Investor [Member] | Subsequent Event [Member]
Common stock price per share		$ 0.005
Investor [Member] | Minimum [Member]
Common stock price per share		0.0025
Investor [Member] | Maximum [Member]
Common stock price per share		$ 0.03
Daniel Crawford [Member] | Series A Preferred Stock [Member]
Preferred Shares issued					5,000,000
Exchange Shares	10,000,000

RELATED PARTY (Details Narrativ

RELATED PARTY (Details Narrative) - USD ($)	1 Months Ended			9 Months Ended
	Oct. 31, 2019	Apr. 16, 2018	Dec. 31, 2017	Dec. 31, 2019	Mar. 31, 2019
Ownership percentage description		the Company entered into an operating agreement with Centre Manufacturing, Inc. (“Centre”) and formed an LLC owned 51% by the Company and 49% owned by Centre, but all income and losses will be split evenly.
LLC [Member]
Ownership percentage		51.00%
Centre [Member]
Ownership percentage		49.00%
Inventory				$ 12,400	$ 76,946
Due to related party				0	26,791
La Dulce Vita Trust [Member]
Due to related party				474,000	474,000
Note Payable				$ 22,000	$ 22,000
Advisory Board Members [Member] | October 1, 2019 [Member]
Stock warrants issued	1,000,000			3,000,000
Stock warrant issued description				the Company appointed three members to an advisory board and issued each member a warrant convertible into 1,000,000 shares
Shares Price				$ 0.01
Ashok Patel [Member]
Common stock, shares issued, Shares			700,000

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details)	Dec. 31, 2019USD ($)
Years Ending March 31,
2020	$ 11,400
2021	45,600
2022	45,600
Aggregate future lease liability expense	$ 102,600

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Additional penalty	$ 114,000
Rent expense	$ 34,200	$ 0

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	1 Months Ended	9 Months Ended
	Jan. 31, 2020	Dec. 31, 2019
Debt instrument converted amount		$ 865,082
Subsequent Event [Member]
Shares Issued		323,200,260
Penalty Settled		$ 5,551
Debt instrument converted amount		$ 46,206
Subsequent Event [Member] | Noteholder Six [Member]
Shares Issued		90,500,260
Penalty Settled
Debt instrument converted amount		$ 21,206
Subsequent Event [Member] | Noteholder Three [Member]
Shares Issued		232,700,000
Penalty Settled	$ 5,551	$ 5,551
Debt instrument converted amount		$ 25,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	9 Months Ended
	Dec. 31, 2019	Mar. 31, 2019
Debt instrument converted amount	$ 865,082
Convertible promissory note [Member]
Common stock share reserve for future issuance for commitment fee	5,300,000,000	398,000,000
Subsequent Event [Member]
Common stock, shares issued upon conversion of debt	323,200,260
Debt instrument converted amount	$ 46,206
Subsequent Event [Member] | Noteholder Six [Member]
Common stock, shares issued upon conversion of debt	90,500,260
Debt instrument converted amount	$ 21,206
Subsequent Event [Member] | February 13, 2020 [Member] | Convertible promissory note [Member] | Noteholder Six [Member]
Notes Payable	$ 100,000
Debt instrument, interest rate	12.00%
Debt instrument, maturity date	Dec. 12, 2020
Debt instrument, conversion, description	Convertible into shares of the Company’s common stock at a 40% discount
Common stock share reserve for future issuance for commitment fee	40,700,000
La Dulce Vita Trust [Member]
Related party debt extinguishment	$ 474,000	$ 474,000
Notes Payable	$ 22,000	$ 22,000
La Dulce Vita Trust [Member] | Subsequent Event [Member] | February 2020 [Member]
Common stock, shares issued upon conversion of debt	800,000
Related party debt extinguishment	$ 474,000
La Dulce Vita Trust [Member] | Subsequent Event [Member] | January 2020 [Member]
Notes Payable	22,000
Debt instrument converted amount	$ 22,580
Choice Wellness Brands, Inc [Member] | Subsequent Event [Member] | February 12, 2020 [Member] | Letter of Intent [Member]
Equity method investment, ownership, percentage	100.00%
Business acquisition, description	The Company will acquire 100% of the ownership of Choice in exchange for the issuance of a new class of preferred stock that will have the effect of giving the shareholders of Choice a 30% equity interest in the Company